Herbal products sit on a regulatory boundary. Positioned as food supplements, they cannot make medicinal claims. Positioned as medicines, they need an authorisation or a registration. For companies that want medicinal claims for a herbal product in Greece and the wider EU, the main decision is which of two pathways the evidence supports: traditional use or well-established use.
Two routes, two evidence standards
Directive 2004/24/EC introduced a simplified registration for traditional herbal medicinal products into Directive 2001/83/EC. In its place, or alongside it, applicants can seek a full marketing authorisation based on well-established medicinal use under Article 10a of the Directive.
- Traditional use registration (THMP): efficacy is accepted on the basis of long-standing use and plausibility, without clinical trials. The product must have been in medicinal use for at least 30 years, including at least 15 years in the EU.
- Well-established use (WEU): efficacy and safety are shown through published scientific literature showing at least ten years of well-established medicinal use in the EU, with recognised efficacy and an acceptable level of safety.
Conditions for the traditional route
Traditional use registration is not available for every herbal product. Among other conditions, the product must:
- have indications appropriate to use without a doctor’s diagnosis, prescription or monitoring
- be intended for use at a specified strength and posology
- be for oral, external or inhalation use
- carry labelling stating that efficacy is based exclusively on long-standing use.
Pharmaceutical quality requirements are not simplified. A THMP must meet the same quality standards as any other medicine, and it is manufactured under GMP.
The role of HMPC monographs
EMA’s Committee on Herbal Medicinal Products (HMPC) publishes European Union herbal monographs that set out the HMPC’s view on traditional and well-established uses of a herbal substance or preparation. They are not legally binding, but national authorities, including EOF, refer to them and they greatly simplify an application. A product that matches a monograph’s preparation, indication and posology has a clear evidential anchor. A product that departs from it needs its own justification.
Common pitfalls
- Building the traditional-use case on evidence for a different extraction solvent, ratio or preparation than the one being registered.
- Indications drafted too broadly for a non-prescription, self-care setting.
- Under-investing in quality: specifications for the herbal substance, contaminants and stability are frequent sources of questions.
- Combining several herbal substances without evidence for the combination itself.
How PQRA helps
PQRA advises on the herbal product boundary, from deciding whether a product should be a food supplement or a medicine to choosing between traditional use and well-established use. We prepare registration and authorisation dossiers for EOF and for mutual recognition and decentralised procedures, and we support the GMP and quality documentation behind them.


No responses yet